BA Stock: Boeing 737 Max Everett Line Restart on July 6

Boeing (NYSE: BA) confirmed that production at its new 737 Max final assembly line in Everett, Washington will begin on July 6. The CEO described the new line as a catalyst for improvement, framing the Everett restart as a tangible step in the company's multi-year recovery plan. For BA holders, July 6 is the first concrete date in months that anchors the operational improvement narrative.

The Everett line addition reflects two structural decisions. First, Boeing needs additional 737 Max production capacity to address backlog. The narrowbody backlog has grown materially in 2024-2026 as airlines maintained order velocity despite delivery delays. Second, the Renton facility — Boeing's historical 737 production hub — has had quality and consistency issues that the company is working through with FAA oversight. Adding Everett distributes risk and provides a backup production path.

Where BA sits operationally

Drillr terminal snapshot (June 6, 2026):

Boeing's roughly flat YTD performance reflects the market's wait-and-see posture on whether the operational recovery is materializing. The forward P/E of 95.2x reflects suppressed earnings (the company has been roughly break-even on a GAAP basis) rather than premium valuation. The Forward P/S of 1.7x is more meaningful — Boeing trades at materially below its historical sales multiple, reflecting durable concerns about quality, production consistency, and execution.

The stock's 7.9 percent TTM EBITDA margin is the cleanest indicator of where operational performance sits. Pre-2019 (pre-MAX grounding), Boeing's EBITDA margins ran in the high teens. The recovery thesis depends on EBITDA margins expanding back toward historical levels as production normalizes.

What the Everett restart actually delivers

The new Everett line provides three operational benefits.

First, capacity. Once at full ramp (estimated 12-18 months from July 6), the line should support an incremental 4-8 737 Max deliveries per month. At a list price of $130-150 million per aircraft, that translates to roughly $500 million to $1 billion in incremental annual revenue. The actual realized revenue runs lower due to airline-negotiated discounts.

Second, redundancy. By distributing 737 Max production across two facilities, Boeing reduces single-point-of-failure risk. If a quality issue emerges at Renton, the Everett line maintains delivery capability. This is a structural improvement in operational reliability.

Third, FAA optics. The new line is being qualified under updated quality management procedures designed to address the criticisms that emerged from the Alaska Airlines door plug incident and subsequent FAA scrutiny. A clean start at Everett demonstrates Boeing's ability to execute under the new framework.

How Wall Street is thinking about BA

The sell-side view on Boeing has gradually shifted from skeptical to cautiously constructive over the past 6-9 months. Analysts focus on three sequential catalysts: 1) production ramp at Renton, 2) Everett line restart and ramp, 3) 777X certification. The Everett restart is the middle catalyst — confirmation of the first one in sequence.

Free cash flow inflection is the financial milestone that would re-rate the stock. Boeing has burned cash through most of 2023-2026 as production was constrained by quality remediation costs and delivery delays. Returning to sustained positive free cash flow is the prerequisite for multiple expansion. Most sell-side models estimate this milestone at late 2026 or early 2027, contingent on production ramping as planned.

For positioning, BA is the kind of stock that responds asymmetrically to operational confirmation. Each milestone successfully delivered tends to produce a 5-10 percent step-up; each delay or quality incident produces a 10-20 percent step-down. The Everett line starting on schedule on July 6 is the next test.

What other catalysts to watch in parallel

The broader Boeing recovery thesis depends on more than just 737 Max production. Three additional catalysts run in parallel:

First, 777X certification. The 777X program has been delayed multiple times. FAA certification timing — most recently expected in late 2026 — would reactivate widebody production economics and provide material revenue and EBITDA contribution.

Second, Air Force One delivery. The two presidential aircraft have been delayed and cost-overrun for years. Delivery would close a multi-billion dollar loss account.

Third, defense segment performance. Boeing's defense, space, and security segment has been a drag on aggregate profitability. Improving execution there would contribute to the consolidated margin recovery.

What to watch next

• July 6 actual production start: Confirmation that the Everett line begins on schedule is the first deliverable. Any delay would reset the recovery timeline expectations.
• Initial Everett line throughput: Watch quarterly production updates for the actual rate at which the line ramps. 4-8 aircraft per month within 12-18 months is the target.
• Q3 Boeing earnings free cash flow: Cash flow inflection is the most important financial signal. Watch for narrowing operating cash burn or positive guidance.
• 777X certification status: Any meaningful update on FAA certification timing would materially affect the 12-24 month thesis.

For positioning, BA's setup is improving but remains binary. Successful execution at Everett extends the operational recovery narrative; any stumble resets the timeline. The 1-year return of just 4 percent reflects investor patience that has not yet been rewarded; July 6 is when that patience gets its first test. The longer-term recovery thesis remains intact, but execution remains the constraint.

---